Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Oliva

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|May 2, 2024
Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary InterventionBenjamin Bay, Raman Sharma, Anastasios Roumeliotis, et al.
European Journal of Preventive Cardiology|December 21, 2024
Validation of a High Bleeding Risk Definition in Cancer Patients undergoing Percutaneous Coronary InterventionMauro Gitto, Sean Gilhooley, Kenneth Smith, et al.
The American Journal of Cardiology|March 29, 2026
Clinical Differences and Disparities Among Men and Women with Acute Myocardial Infarction-Related Cardiogenic Shock Undergoing Percutaneous Coronary InterventionMadison Edens, Angelo Oliva, Samantha Sartori, et al.
Atherosclerosis|October 10, 2025
Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary interventionAngelo Oliva, Mark Shneyderman, Mauro Gitto, et al.
Circulation|October 23, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized TrialsUsman Baber, Yangsoo Jang, Angelo Oliva, et al.
The American Journal of Cardiology|October 24, 2024
Clinical Outcomes After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease in Patients of Diverse Race/EthnicityPier Pasquale Leone, Samantha Sartori, Jonathan Murphy, et al.
Circulation. Cardiovascular Interventions|October 24, 2023
Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending ArteryMauro Gitto, Alessandro Sticchi, Mauro Chiarito, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2024
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery interventionAnastasios Roumeliotis, Gerasimos Siasos, George Dangas, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|May 2, 2024
Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary InterventionBenjamin Bay, Raman Sharma, Anastasios Roumeliotis, et al.
European Journal of Preventive Cardiology|December 21, 2024
Validation of a High Bleeding Risk Definition in Cancer Patients undergoing Percutaneous Coronary InterventionMauro Gitto, Sean Gilhooley, Kenneth Smith, et al.
The American Journal of Cardiology|March 29, 2026
Clinical Differences and Disparities Among Men and Women with Acute Myocardial Infarction-Related Cardiogenic Shock Undergoing Percutaneous Coronary InterventionMadison Edens, Angelo Oliva, Samantha Sartori, et al.
Atherosclerosis|October 10, 2025
Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary interventionAngelo Oliva, Mark Shneyderman, Mauro Gitto, et al.
Circulation|October 23, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized TrialsUsman Baber, Yangsoo Jang, Angelo Oliva, et al.
The American Journal of Cardiology|October 24, 2024
Clinical Outcomes After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease in Patients of Diverse Race/EthnicityPier Pasquale Leone, Samantha Sartori, Jonathan Murphy, et al.
Circulation. Cardiovascular Interventions|October 24, 2023
Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending ArteryMauro Gitto, Alessandro Sticchi, Mauro Chiarito, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2024
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery interventionAnastasios Roumeliotis, Gerasimos Siasos, George Dangas, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
Pageof 7